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ABSTRACT The opportunistic human fungal pathogen Candida albicans can cause
a variety of diseases, ranging from superﬁcial mucosal infections to life-threatening
systemic infections. Phagocytic cells of the innate immune response, such as neutro-
phils and macrophages, are important ﬁrst-line responders to an infection and gen-
erate reactive oxygen and nitrogen species as part of their protective antimicrobial
response. During an infection, host cells generate nitric oxide through the enzyme in-
ducible nitric oxide synthase (iNOS) to kill the invading pathogen. Inside the phagocyte,
iNOS competes with the enzyme arginase-1 for a common substrate, the amino acid
L-arginine. Several pathogenic species, including bacteria and parasitic protozoans, ac-
tively modulate the production of nitric oxide by inducing their own arginases or the
host’s arginase activity to prevent the conversion of L-arginine to nitric oxide. We report
here that C. albicans blocks nitric oxide production in human-monocyte-derived macro-
phages by induction of host arginase activity. We further determined that puriﬁed chitin
(a fungal cell wall polysaccharide) and increased chitin exposure at the fungal cell wall
surface induces this host arginase activity. Blocking the C. albicans-induced arginase ac-
tivity with the arginase-speciﬁc substrate inhibitor N-hydroxy-nor-arginine (nor-NOHA)
or the chitinase inhibitor bisdionin F restored nitric oxide production and increased the
efﬁciency of fungal killing. Moreover, we determined that C. albicans inﬂuences mac-
rophage polarization from a classically activated phenotype toward an alternatively
activated phenotype, thereby reducing antimicrobial functions and mediating fungal
survival. Therefore, C. albicans modulates L-arginine metabolism in macrophages dur-
ing an infection, potentiating its own survival.
IMPORTANCE The availability and metabolism of amino acids are increasingly recog-
nized as crucial regulators of immune functions. In acute infections, the conversion of
the “conditionally essential” amino acid L-arginine by the inducible nitric oxide synthase
to nitric oxide is a resistance factor that is produced by the host to ﬁght pathogens. Ma-
nipulation of these host defense mechanisms by the pathogen can be key to successful
host invasion. We show here that the human opportunistic fungal pathogen Candida al-
bicans inﬂuences L-arginine availability for nitric oxide production by induction of the
substrate-competing host enzyme arginase-1. This led to a reduced production of nitric
oxide and, moreover, reduced eradication of the fungus by human macrophages. We
demonstrate that blocking of host arginase-1 activity restored nitric oxide production
and increased the killing potential of macrophages. These results highlight the therapeu-
tic potential of L-arginine metabolism in fungal diseases.
Candida albicans is an opportunistic fungal pathogen that frequently colonizes themucosal surfaces of healthy individuals without causing infection (1). However, in
individuals in whom the normally suppressive endogenous bacterial microﬂora is
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disturbed, in patients experiencing severe trauma or surgery, immunocompromised
individuals, or those undergoing immunosuppressive therapies, C. albicans is a frequent
cause of mucocutaneous or disseminated infections (2). Phagocytic cells, such as
macrophages and neutrophils, are important mediators of innate immunity and are
responsible for developing a robust antimicrobial response after recognition and
ingestion of pathogens (3). The synthesis of antimicrobial effectors, such as reactive
oxygen species (ROS) and reactive nitrogen species (RNS), is an important cornerstone
of the phagocyte antimicrobial response. Nitric oxide (NO) in macrophages is produced
by the inducible nitric oxide synthase (iNOS, NOS2), which catalyzes the conversion of
the amino acid L-arginine to NO and citrulline. NO is a central component of phagocyte
innate immunity and can react with superoxide to peroxynitrite, an effective cytotoxic
antimicrobial agent against intracellular and extracellular pathogens, such as Mycobac-
terium tuberculosis and Escherichia coli (4).
iNOS is not present in resting cells but can be induced by immunostimulatory type
1 cytokines, such as interferon gamma (IFN-), tumor necrosis factor alpha (TNF-), and
interleukin-1 (IL-1), but also by microbial cell wall components, such as lipopolysac-
charide (LPS) and lipoteichoic acid (LTA), during an infection (5). The availability of
L-arginine is a rate-limiting factor in NO synthesis (6), and in mammalian cells, iNOS
competes with the enzyme arginase-1 (Arg-1) for the substrate L-arginine. Arginase-1
can be induced in macrophages by type 2 cytokines, such as IL-4, IL-13, IL-10, and
transforming growth factor beta (TGF-), inhibiting iNOS functions and leading to
increased humoral immunity, tissue repair, and allergic responses (7). Additionally,
polyamines produced in the arginase pathway downregulate proinﬂammatory cytokine
release. The critical interplay between arginase-1 and iNOS is important in inﬂuencing
the outcome of an infection, and several pathogens have been shown to regulate this
important pathway either by modulating L-arginine availability through induction of
host arginases or by using their own arginases to metabolize host L-arginine (reviewed
in reference 4).
C. albicans has been shown to actively block the production of NO by macrophages,
although the modulating factor and the underlying mechanisms are not known (8–10).
Here, we link C. albicans NO suppression to cell wall changes occurring during the
C. albicans response to macrophages and adaptation to the phagosome environment.
We show that the fungal cell wall polysaccharide chitin induces host arginase-1
expression and activity, thereby suppressing NO synthesis. Moreover, this interference
with host L-arginine metabolism shifts classically activated macrophages toward an
alternative activated phenotype, enhancing C. albicans survival.
RESULTS
C. albicans inﬂuences host arginase activity. We hypothesized that C. albicans
promotes its own survival in phagocytes by manipulating the availability of L-arginine
for NO synthesis. We therefore analyzed the induction of iNOS and arginase-1 protein
expression in IFN-- and LPS-activated human monocyte-derived macrophages, cocul-
tured with C. albicans (multiplicity of infection [MOI]  1) for 3 h by immunoblotting
(Fig. 1A). C. albicans signiﬁcantly increased both iNOS and arginase-1 (Arg-1) protein
expression, although the total increase in protein level was higher for Arg-1 (7.43-
fold  1.61-fold) than for iNOS (1.21-fold  0.05-fold). We next examined NO produc-
tion by measuring the amount of nitrite in the supernatants of the same cocultures
(Fig. 1B). Interestingly, although a slightly increased iNOS protein level was detected,
we observed a 50% reduction of NO released from the activated macrophages in the
presence of C. albicans (Fig. 1B). However, the observed increased arginase-1 protein
expression led to a 40% increase in arginase activity in the analyzed cell lysates (Fig. 1C).
To prove that the reduced NO production was due to the observed host arginase-1
induction and not due to upregulation of the fungal NO detoxiﬁcation mechanism, we
added the selective arginase-1 inhibitor N-hydroxy-nor-arginine (nor-NOHA) to block
arginase activity (11). This restored C. albicans-suppressed NO levels in cocultured
macrophages to levels observed in macrophages that were not exposed to C. albicans
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(Fig. 1D). The increased arginase activity in macrophages cocultured with C. albicans
was also reduced by nor-NOHA to levels observed in nor-NOHA-treated activated
macrophages in the absence of C. albicans (Fig. 1E). Therefore, we conclude that the
presence of C. albicans increased arginase-1 activity in IFN-- and LPS-activated human
monocyte-derived macrophages, limiting the availability of L-arginine for NO produc-
tion by iNOS.
Increased arginase activity is chitin mediated and leads to reduced macro-
phage antimicrobial function. Next, we determined the impact of increased arginase
activity and blocked NO production on antimicrobial macrophage function and C. al-
bicans germ tube formation. Blocking arginase activity with nor-NOHA signiﬁcantly
increased fungal uptake (Fig. 2A) and killing (Fig. 2B) by IFN-- and LPS-activated
human monocyte-derived macrophages. Moreover, reduced arginase activity led to
decreased C. albicans hyphal extension inside macrophage phagosomes (Fig. 2C). Germ
tube formation of nonphagocytosed C. albicans was not affected by nor-NOHA treat-
ment (Fig. 2D). Incubation of C. albicans with nor-NOHA in the absence of macrophages
did not impact Candida viability (Fig. 2B) or germ tube formation (Fig. 2C and D).
Arginase-1 induction in macrophages can be induced by type 2 cytokines, such as
IL-4, IL-10, and IL-13 (7). Chitin is a cell wall polysaccharide which is a potent stimulator
of allergic responses, and we showed previously that puriﬁed fungal chitin induces
IL-10 secretion in human myeloid cells (12). Therefore, we tested the ability of puriﬁed
fungal chitin to induce arginase protein expression and arginase activity in IFN-- and
LPS-activated human monocyte-derived macrophages (Fig. 3). C. albicans-derived chitin
increased arginase-1 protein levels but did not induce iNOS expression (Fig. 3A).
Arginase activity was, however, signiﬁcantly increased in chitin-stimulated macro-
phages (Fig. 3B), whereas NO synthesis was reduced (Fig. 3C). Next, we determined
whether chitin on the surface of C. albicans was accessible for immune recognition by
macrophages. We stained C. albicans cells that had been cocultured with IFN-- and
LPS-activated human monocyte-derived macrophages for 3 h, both phagocytosed and
nonphagocytosed cells, for -glucan (red) and chitin (green) exposure (Fig. 4A). C. al-
bicans cells recovered from macrophage phagosomes showed signiﬁcantly increased
chitin surface exposure, but no major changes in -glucan exposure were observed
(Fig. 4B). To test whether chitin released from phagocytosed C. albicans by the activity
FIG 1 C. albicans impacts macrophage NO production by inducing host arginase activity. (A) iNOS and
arginase-1 protein levels in IFN-/LPS-activated human-monocyte-derived macrophages after coincuba-
tion with live C. albicans (Ca) for 3 h (n  4; *, P  0.05); (B) NO inhibition by C. albicans as determined
by measuring nitrite levels (n 6; **, P 0.01); (C) arginase enzyme activity as determined by measuring
the conversion of arginine to urea (n  4; *, P  0.05); (D and E) NO synthesis (D) and arginase activity
(E) of IFN-/LPS-activated macrophages left untreated or preincubated with 25 M nor-NOHA for 30 min
to block arginase activity before coincubation with live C. albicans cells for 3 h (n  6; *, P  0.05; **,
P  0.01). Arginase activity and NO levels are expressed as percentages of levels generated by
IFN-/LPS-activated macrophages alone (control [ctrl]). All data are presented as mean values  SD.
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of acidic mammalian chitinase (AMCase) was responsible for the reduced antimicrobial
activity of the macrophages, we preincubated the macrophages with the AMCase-
speciﬁc inhibitor bisdionin F. Inhibition of AMCase activity resulted in an increase in
C. albicans phagocytosis (Fig. 4C) and killing (Fig. 4D) by the macrophages, comparable
to the increase observed with nor-NOHA treatment (Fig. 4C and D). Neither chemical
FIG 2 The inhibition of arginase activity impacts macrophage functions. IFN-/LPS-activated macrophages were
either untreated or preincubated with 25 M nor-NOHA for 30 min to block arginase activity before being
coincubated with live C. albicans cells for 3 h. (A) The uptake of C. albicans by the macrophages was determined
microscopically. Pictures shown are representative of three independent experiments. Stars indicate macrophages
containing multiple Candida cells. Scale bar  50 m. The phagocytic index (PI) was calculated according to the
following formula: PI  (percentage of phagocytic cells containing 1 Candida cell)  (mean number of Candida
cells/phagocytic cell containing Candida) (n  6; **, P  0.01). A minimum of 100 macrophages was counted for
each condition. (B) C. albicans survival in control culture and macrophage cocultures (co-cult.) was determined by
CFU microdilution spot assays. CFU are expressed as percentages of C. albicans cells killed by macrophages
compared to numbers present in control samples (C. albicans alone) (n  4; *, P  0.05). The spot assay shown is
representative of three independent experiments. (C and D) Hypha formation of controls and phagocytosed (C) and
nonphagocytosed (D) C. albicans cells was determined microscopically, and hyphal length was measured using
ImageJ. A minimum of 100 hyphae/germ tube was counted for each condition (n  4; **, P  0.01). All data are
presented as mean values  SD.
FIG 3 Puriﬁed fungal chitin induces arginase activity. (A) iNOS and arginase-1 protein levels in
IFN-/LPS-activated macrophages stimulated with 10 g/ml puriﬁed C. albicans chitin for 3 h. Blots
shown are representative of two independent experiments with four donors. (B and C) Arginase enzyme
activity induced by puriﬁed C. albicans chitin (B) and NO inhibition by C. albicans chitin (C). Arginase
activity and NO levels are expressed as percentages of levels generated by IFN-/LPS-activated macro-
phages alone (ctrl) (n  4; **, P  0.01). All data are presented as mean values  SD.
Wagener et al. ®
January/February 2017 Volume 8 Issue 1 e01820-16 mbio.asm.org 4
 
m
bio.asm
.org
 o
n
 January 31, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
(nor-NOHA or bisdionin F) altered chitin surface exposure (see Fig. S1A in the supple-
mental material), C. albicans viability (Fig. S1B and Fig. 2B), or hyphal extension (Fig. S1C
and Fig. 2C) when added directly to the cells.
Therefore, exposed chitin in the cell wall of C. albicans led to increased activity of
arginase-1 in IFN-/LPS-activated human monocyte-derived macrophages, thereby
reducing C. albicans killing.
A chitin-mediated increase in arginase activity requires active fungal cell wall
remodeling
and correlates with C. albicans virulence. Increased chitin surface exposure may be
driven by C. albicans cell wall remodeling in response to the phagosome environment,
similar to the increased chitin deposition in the cell wall described after an attack by
neutrophils (13) and/or unmasking by the actions of host enzymes or exposure to
echinocandins (e.g., caspofungin) (14). We therefore coincubated IFN-/LPS-activated
human monocyte-derived macrophages with nonviable yeast cells (thimerosal-treated
yeast cells [THY]) for 3 h and determined macrophage NO production and arginase-1
activity, as well as the surface exposure of -glucan and chitin of control samples, for
both nonphagocytosed and phagocytosed THY (Fig. 5). Nonviable C. albicans cells did
not signiﬁcantly reduce NO production (Fig. 5A) or induce arginase activity (Fig. 5B). Cell
wall staining revealed that phagocytosis by macrophages did not signiﬁcantly alter the
cell surface presentation of -glucan or chitin in nonviable yeast cells during the
experimental time course (3 h) (Fig. 5C).
C. albicans cell wall remodeling during infection is predicted to have a signiﬁcant
impact on signaling pathways important for mounting a protective immune response
FIG 4 Increased chitin exposure of phagocytosed C. albicans. (A) C. albicans was cocultured with
IFN-/LPS-activated macrophages for 3 h. Nonphagocytosed C. albicans cells were collected from the
supernatants and washes of adherent macrophages. Phagocytosed C. albicans cells were released by
macrophage lysis. Fungal cells were stained for -glucan and chitin exposure using Fc–dectin-1–
tetramethyl rhodamine isocyanate (TRITC) (red), wheat-germ agglutinin (WGA)-FITC (green), and calco-
ﬂuor white (blue). Pictures shown are representative of results from three independent experiments. (B)
The ﬂuorescence (FL) intensity of Fc–dectin-1–TRITC, WGA-FITC, and CFW staining was determined using
ImageJ. Minimally 50 cells were analyzed. -glucan and chitin exposure is expressed as FL-1 (WGA-FITC
or Fc–dectin-1–TRITC)/FL-2 (CFW) (**, P  0.01). (C and D) IFN-/LPS-activated macrophages were left
untreated or were preincubated with 25 M nor-NOHA or 50 M bisdionin F (BisF) for 30 min before
being coincubated with live C. albicans cells for 3 h. (C) The uptake of C. albicans cells by the
macrophages was determined microscopically, and minimally 100 macrophages were counted for each
condition to determine the PI (n  4; **, P  0.01). (D) C. albicans survival in macrophage cocultures was
determined by a CFU microdilution assay. CFU are expressed as percentages of C. albicans cells killed by
macrophages compared to those present in control samples (C. albicans alone) (n  4; *, P  0.05). All
data are presented as mean values  SD.
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(15, 16). In vivo infection with different C. albicans strains from different multilocus
sequence type (MLST) clades revealed that mice deﬁcient in the major -glucan
receptor dectin-1 can exhibit a protective immune response in a strain-dependent
manner. Interestingly, the pathogenicity of the strains used in this study correlated with
increased chitin levels observed in vivo (16). We therefore tested four additional
C. albicans strains with different virulence attributes for their ability to increase mac-
rophage arginase activity and to reduce NO production (Table 1; Fig. 5). Levels of
induction of arginase activity and reduction of NO synthesis varied between the strains
and correlated with their reported in vivo pathogenicity (Table 1) (17). Strains classiﬁed
as virulent (SC5314, J990102) in a systemic mouse model of C. albicans infection and an
untested clinical isolate (AM12/0005) induced the highest arginase activity in IFN-/
LPS-activated human monocyte-derived macrophages after 3 h and signiﬁcantly
blocked NO production (Fig. 5D and E). The intermediate (AM2003/0182) and attenu-
ated (RV4688) strains did not signiﬁcantly change arginase activity (Fig. 5D) or NO
synthesis (Fig. 5E).
We therefore conclude that increased chitin exposure is actively driven by fungal
cell wall remodeling and that the levels of arginase activity induction and reduction of
FIG 5 A chitin-mediated increase in arginase activity requires active fungal cell wall remodeling and
correlates with C. albicans virulence. IFN-/LPS-activated macrophages were coincubated with
thimerosal-treated C. albicans yeast cells (THY) or live C. albicans cells for 3 h. (A and E) NO inhibition by
THY (A) and live C. albicans cells (E) (n  4; **, P  0.01). (B and D) Arginase enzyme activity (n  3; *,
P  0.05). Arginase activity and NO levels are expressed as percentages of the levels generated by
IFN-/LPS-activated macrophages alone (ctrl). (C) THY were cocultured with IFN-/LPS-activated macro-
phages for 3 h. Nonphagocytosed THY were collected from the supernatants and washes of adherent
macrophages. Phagocytosed THY were released by macrophage lysis. Fungal cells were stained for cell
wall mannans (concanavalin A), -glucan (Fc–dectin-1–TRITC), and chitin (WGA-FITC and calcoﬂuor
white). Fluorescence intensity of staining was determined using ImageJ. Minimally 20 cells were
analyzed. Mannan, -glucan, and chitin exposure is expressed as FL-1 (concanavalin A, WGA-FITC, or
Fc–dectin-1–TRITC)/FL-2 (CFW). All data are presented as mean values  SD.
TABLE 1 Characteristics of strains used in this study
Strain
Anatomical
source MLST clade
Virulence
attributea Reference
SC5314 Blood 1 Virulent 50
AM2012/0005 Blood Unknown Not tested Unpublished
AM2003/0182 Blood 2 Intermediate 17
J990102 Vagina 3 Virulent 17
RV4688 Blood 4 Attenuated 17
aMouse systemic model.
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NO synthesis are C. albicans strain speciﬁc and correlate with the virulence attributes of
the tested strains.
Puriﬁed fungal chitin and C. albicans surface-exposed chitin inﬂuence the
macrophage phenotype. Macrophage activation depends on stimuli present in their
immediate environment. Macrophages adapt to environmental signals, such as cyto-
kines produced by surrounding cells (7). This leads to ﬂexibility in macrophage pro-
graming, enabling macrophages to switch readily from one functional phenotype to
another in response to changing microenvironmental signals. Pathogen- and damage-
associated molecular patterns, together with IFN-, polarize macrophages toward an
M1 phenotype, characterized by the production of ROS and RNS, which facilitate the
killing of microbial pathogens. In contrast to M1 macrophages, alternatively activated
M2 macrophages suppress inﬂammation and facilitate wound repair. High arginase
activity has been described for the M2 macrophage phenotype, which is important in
facilitating the production of prolines required for wound healing (18). To determine
whether the chitin-induced increase in arginase activity is also impacted the macro-
phage phenotype, we analyzed the expression of macrophage phenotype-speciﬁc
markers by ﬂow cytometry to distinguish macrophage phenotypes (Fig. 6).
Up to 70% of the in vitro-differentiated IFN-/LPS-activated macrophages expressed
markers characteristic of the M1 phenotype (Fig. 6). Stimulation with puriﬁed fungal
chitin signiﬁcantly reduced this M1 population while simultaneously signiﬁcantly in-
creasing the proportion of cells expressing M2 markers (Fig. 6B). To overcome technical
restrictions on using live C. albicans cells in ﬂow cytometry due to hyphal formation, we
mimicked the increased chitin surface expression observed in live C. albicans cells
(Fig. 4) by pretreating yeast cells with caspofungin, a cell wall-targeting antifungal drug
which increases the exposure of both chitin and -glucan (19, 20), before inactivating
the yeast cells chemically with thimerosal to preserve the cell wall changes. Macro-
phages stimulated with untreated C. albicans cells showed no change in polarization
markers, whereas macrophages stimulated with caspofungin-treated yeast cells
showed a decrease in the M1 population and a signiﬁcant increase in the M2 macro-
phage population (Fig. 6C), which was comparable to levels induced by puriﬁed fungal
chitin alone (Fig. 6B). Therefore, the recognition of puriﬁed fungal chitin and exposed
cell wall chitin shifted the equilibrium from M1 to M2 macrophages.
Macrophage phenotype is an important determinant of the antifungal re-
sponse to C. albicans. Immune surveillance and tissue homeostasis is an important
task of tissue-resident macrophages. Tissue-resident macrophages, alongside other
tissue-resident cells, such as stromal cells, mast cells, and dendritic cells, respond to
pathogens by initiating inﬂammation. The initial pathogen encounter drives the inﬂux
of neutrophils and inﬂammatory monocytes, the source of inﬂammatory macrophages
FIG 6 Puriﬁed fungal chitin and increased cell wall chitin exposure of C. albicans changes macrophage
polarization. (A) The gating strategy was that classically activated macrophages (M1) were deﬁned as
CD68pos CD80high CD163low CD206int (where “pos” is positive and “int” is intermediate) and alternatively
activated macrophages (M2) as CD68pos CD80low CD163high CD206high. (B and C) IFN-/LPS-activated
macrophages were stimulated with 10 g/ml puriﬁed C. albicans chitin for 24 h (B) or with heat-
inactivated C. albicans (with or without caspofungin treatment [Cfg]) (C), and the expression of CD80,
CD163, and CD206 was determined by ﬂow cytometry (n  4; *, P  0.05; **, P  0.01). All data are
presented as mean values  SD.
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(M1), as part of the antimicrobial defense (21). Tissue-resident macrophages are clas-
siﬁed as M2-like due to their functional similarity to M2 macrophages. We therefore
tested the inﬂuence of C. albicans on arginase activity and NO production in tissue-
resident macrophages. We repeated the coincubation experiments with nonactivated
(resting) and IFN-/LPS-activated human monocyte-derived macrophages (Fig. 7A and
B) and, in addition, challenged nonactivated and IFN-/LPS-activated murine peritoneal
(tissue-resident) macrophages (Fig. 7C and D) with C. albicans. We found that resting
and tissue-resident macrophages secreted very low levels of nitric oxide (Fig. 7A and C)
and that NO production increased upon activation with IFN-/LPS (Fig. 7B and D),
which supports the results of prior reports (5). Coincubation with C. albicans did not
impact NO levels in nonactivated macrophages (Fig. 7A and C). However, coincubation
with C. albicans signiﬁcantly increased the arginase activity in both nonactivated
human macrophages and mouse peritoneal macrophages (Fig. 7B and D).
Alternative activation of macrophages is complex, and several macrophage sub-
types have been described in the literature (7, 18). In general, M2 macrophages are
marked by increased anti-inﬂammatory cytokine production (e.g., IL-10, TGF-, IL-1RA)
and increased expression of C-type lectins (CTLs) (e.g., dectin-1, dendritic cell-speciﬁc
intercellular adhesion molecule-3-grabbing nonintegrin [DC-SIGN], and mannose re-
ceptor) and scavenging receptors for the uptake of cellular debris (7). Alternative
activation of macrophages due to Th2 responses (e.g., IL-4 and IL-13) has been shown
to promote fungal persistence, allergy, and disease relapse, and neutralization of
endogenous IL-4 has beneﬁcial effects on the survival of mice systemically infected with
C. albicans (22). When we challenged alternatively (IL-4) activated macrophages with
live C. albicans, we found that these macrophages were more potent in their ability to
phagocytose C. albicans than IFN-/LPS-activated (M1) macrophages (Fig. 8A). Al-
though hypha formation of nonphagocytosed (Fig. 8B) and phagocytosed C. albicans
(Fig. 8C) cells was signiﬁcantly suppressed compared to that in M1 macrophages,
alternatively activated macrophages showed a markedly reduced ability to kill C. albi-
cans (Fig. 8B).
In summary, classical macrophage activation is important for pathogen eradication,
and an increased alternative activation of macrophages may result in increased C. al-
bicans persistence following tissue invasion.
FIG 7 C. albicans induced host arginase activity in resting and tissue-resident macrophages. (A and C)
NO inhibition by C. albicans in human monocyte-derived macrophages (A) and mouse peritoneal
macrophages (C) (n  4); (B and D) C. albicans-induced arginase enzyme activity in human monocyte-
derived macrophages (B) and mouse peritoneal macrophages (D) (n  4). Data are presented as mean
values  SD. *, P  0.05; **, P  0.01.
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DISCUSSION
Amino acid metabolism has been increasingly recognized as an important modu-
lator of immune responses (23). The amino acid L-arginine is classiﬁed as “conditionally
essential,” depending on the developmental state and health status of an individual (6).
During an infection, L-arginine availability has been shown to be a crucial regulator of
immune functions, and several pathogens, such as Salmonella and Leishmania spp., can
impact host L-arginine metabolism in various ways (4). In this study, we show that the
human-pathogenic fungus C. albicans alters macrophage nitric oxide production by
affecting host arginase-1 expression and activity. Furthermore, we identiﬁed fungal cell
wall chitin as an important component that mediates arginase-1 induction in human
macrophages.
Previous studies have reported that C. albicans can suppress nitric oxide production
in IFN-/LPS-activated primary mouse macrophages and in activated cell lines
(RAW264.7 and J774.A1) (8–10). A common observation in these studies was that NO
inhibition was highest when live C. albicans cells were in direct contact with macro-
phages. A decrease in iNOS expression (mRNA/protein) was observed with C. albicans
(8, 10) and coculture (9) supernatants. In contrast, our results with human IFN-/LPS-
activated macrophages showed a slight increase in iNOS protein induced by C. albicans,
but this did not result in higher enzyme activity as measured by nitric oxide production.
Therefore, the reduced NO response of human macrophages to C. albicans was not
likely to be due to transcriptional downregulation of the iNOS gene. Inhibition of NO
production was also not mediated by Candida-generated competitive inhibitors (9). We
determined that reduced NO production was most likely to be due to competition for
the L-arginine substrate by the host arginase-1 enzyme. Blocking arginase-1-mediated
consumption of its substrate L-arginine by the substrate inhibitor nor-NOHA restored
NO production in C. albicans-challenged human macrophages and decreased C. albi-
cans survival.
Using a transwell system, Collette et al. (9) showed that direct cell-cell contact was
not necessary for reduced nitric oxide production and that it also occurred in response
to conditioned cell-free supernatants from macrophage-Candida cocultures. They de-
scribed a “secreted” mediator as a small, aqueous, and heat-stable compound. Chitin is
a heat-stable carbohydrate that is released from the fungal cell wall by human
FIG 8 Alternatively activated macrophages restrict C. albicans growth but fail to eradicate the fungus.
The uptake of C. albicans by IFN-/LPS (M1)- or IL-4 (M2)-activated macrophages was determined
microscopically, and minimally 100 macrophages were counted for each condition. The PI was calculated
(n  4; **, P  0.01). Scale bar  50 m. (B and C) The hypha formation of nonphagocytosed (B) and
phagocytosed (C) C. albicans cells was determined microscopically, and hyphal length was measured
using ImageJ. Two hundred hyphae/germ tube were counted for each condition (*, P  0.05; **, P 
0.01). (D) C. albicans survival in control culture and macrophage cocultures was determined by a CFU
microdilution spot assay. The spot assay results shown are representative of three independent experiments.
CFU are expressed as percentages of C. albicans cells killed by macrophages compared to numbers of cells
in control samples (C. albicans alone) (n  5). All data are presented as mean values  SD.
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chitinases during macrophage-Candida interactions (12) and is, therefore, a credible
candidate for this class of mediator. Chitin is also known to induce alternatively
activated macrophages in mouse lungs, which are marked by a high expression of the
enzyme arginase-1 (24). Although chitin in the native cell wall is covered by a layer of
mannoproteins, we showed that chitin can be exposed during C. albicans-macrophage
interactions and that C. albicans chitin is a strong inducer of arginase-1 activity in
human macrophages. Exposure of underlying cell wall layers has also been shown
to occur when C. albicans is attacked by neutrophils (13). Using a speciﬁc inhibitor
(bisdionin F) for the human acidic mammalian chitinase (AMCase) to prevent chitin
release from the cell walls of phagocytosed C. albicans cells, we demonstrated that
chitin release negatively inﬂuenced macrophage antimicrobial functions. Moreover,
chitin recognition inﬂuenced macrophage polarization, pushing macrophages from
a classically activated, antimicrobial phenotype toward an alternatively activated
phenotype, thereby decreasing antimicrobial activity. The ability of C. albicans to
inﬂuence macrophage activation and phenotype has been show previously (25, 26),
although the impact on antimicrobial functions and C. albicans survival was not
determined.
Alternative activation of macrophages by C. albicans in the context of the local
immune response may have either beneﬁcial or detrimental effects for the host. The
activation of a protective Th1/Th17 response is important for the host to clear an
infection, but uncontrolled inﬂammation leads to overinduction and immunopathol-
ogy. Maintaining the correct balance of the host’s immune response is therefore crucial
for the clearance of an infection and the resolution of inﬂammation. In this context, the
predominant, but not exclusive, induction of classical macrophages has been shown to
be protective against several fungal species, including Cryptococcus neoformans, Asper-
gillus fumigatus, and C. albicans, whereas a predominant induction of alternative
macrophages is implicated in the protection against Pneumocystis spp. (18). Interest-
ingly, the recognition of chitin and the activity of the mammalian chitinase chitotrio-
sidase have recently been shown to mediate pathological Th2-associated inﬂammation
during C. neoformans lung infection in vivo (27). Further, the abrogation of IL-4 receptor
-dependent alternative activation of macrophages can mediate resistance to pulmo-
nary C. neoformans infection marked by reduced arginase-1 expression and increased
nitric oxide production (28). The importance of developing a protective Th1/Th17
response over a nonprotective Th2 response in clearing fungal infections has been
described previously (29), and the negative impact of IL-4 in macrophage activation
during fungal infection is linked to fungal persistence (22).
We show here that alternatively (IL-4) activated human macrophages have increased
phagocytic capabilities and an enhanced ability to suppress C. albicans hypha forma-
tion, but they fail to eradicate the fungus. C. albicans can utilize amino acids, such as
L-arginine, as an alternative carbon source under conditions where other carbon
sources, such as glucose, are limited (30). Such conditions are predicted to exist
inside phagosomes (31, 32), and gene transcription analysis conﬁrmed that expres-
sion of C. albicans genes coding for arginine import and degradation are increased
after phagocytosis by macrophages (30). Moreover, increased arginine catabolism
was shown to be important for phagosome alkalinization, hyphal induction, and
macrophage escape (30, 33). The restricted availability of host L-arginine as an
energy source, due to high arginase-1 activity in alternatively activated macro-
phages, can explain the reduced hypha formation (intra- and extracellular) ob-
served in these experiments.
In humans, arginase-1 is constitutively expressed in granulocytes and has been
shown to participate in neutrophil antifungal activity, possibly through arginine deple-
tion (34, 35). On the other hand, arginase-1 release after granulocyte cell death at the
site of inﬂammation and the exocytosis of arginase-1-containing granules due to
“frustrated phagocytosis” has been shown to suppress T-cell proliferation and cytokine
synthesis (34, 36, 37). Sustained arginase-1 activity can also deplete extracellular
L-arginine levels, thereby impairing not only T-cell function (38, 39) but also NK cell
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activation (40). Increased arginase activity occurs as a result of tissue injury and
subsequent wound healing, cancer, cystic ﬁbrosis, or sepsis, thereby increasing suscep-
tibility to secondary infections, including mycoses (41–44). Alternatively, increased
macrophage arginase-1 expression has been shown to be important in the suppression
of T-cell-mediated immunopathology in a mouse model of Mycobacterium tuberculosis
infection (45). These observations highlight the importance of L-arginine metabolism
mediated by arginase-1 in the resolution of inﬂammation.
In summary, our ﬁndings demonstrate that changes in the exposure of C. albicans
cell wall chitin can inﬂuence macrophage functions by impacting host L-arginine
metabolism. Our data reveal an increased fungal killing potential of macrophages if
either host chitinase (bisdionin F) or arginase (nor-NOHA) activity is reduced. Thera-
peutic inhibition of arginase-1 has been shown to have beneﬁcial effects for other
diseases, such as asthma, cancer, and parasitic infections, and shows potential as a
therapeutic target to explore in fungal diseases.
MATERIALS AND METHODS
Monocyte isolation, puriﬁcation, and macrophage differentiation. Blood from healthy volunteers
was collected according to the local guidelines and regulations, approved by the College Ethics Review
Board of the University of Aberdeen (CERB/2012/11/676). Peripheral blood mononuclear cells (PBMCs)
were isolated by Ficoll-Paque Plus (GE Healthcare) density centrifugation according to the manufacturer’s
instructions. Further, highly pure unlabeled monocytes were obtained from PBMCs by depletion of
nonmonocytes using a magnetically activated cell sorting (MACS) system together with a human
pan-monocyte isolation kit (Miltenyi Biotec, Inc.). Puriﬁed monocytes were washed twice with phosphate-
buffered saline (PBS), and cells were suspended in RPMI 1640 (Dutch modiﬁcation) supplemented with
10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 1 mM sodium pyruvate, 1% minimum
essential medium (MEM), nonessential amino acids (NEAA [100]; Gibco), 100 U/ml penicillin, and
100 mg/ml streptomycin. An aliquot of 50 ng/ml recombinant human granulocyte-macrophage colony-
stimulating factor (hGM-CSF) (Gibco) was added to differentiate monocytes into an M1-like polarized
phenotype, and recombinant hM-CSF (Gibco) was added to generate an M2-like polarized phenotype.
Cells were seeded into cell culture dishes at a density of 1  106 cells/cm2 and incubated at 37°C in a
humidiﬁed atmosphere containing 5% CO2, and fresh medium containing recombinant cytokines was
added every other day. After 5 to 7 days, cells were collected, seeded into 12- or 24-well plates at a
density of 5  105 cells or 2  105 cells/well, respectively, and left overnight to adhere. M1-polarized
macrophages were fully activated by adding 100 ng/ml IFN- and LPS, and M2-polarized macrophages
were activated by adding 20 ng/ml IL-4 for 24 h.
Isolation of mouse peritoneal macrophages. C57BL/6 (wild-type) mice were bred and housed
under pathogen-free conditions in the registered animal facility at the University of Aberdeen. All animal
work at the University of Aberdeen is regulated under the UK Home Ofﬁce’s Animals (Scientiﬁc
Procedures) Act of 1986 (ASPA) (46) and European Directive 2010/63/EU (47). All work is approved by the
University of Aberdeen Animal Welfare and Ethical Review Body (AWERB). A total of four mice were used
in this study.
Peritoneal macrophages were isolated from 12- to 16-week-old female mice. Mice were euthanized
by cervical dislocation and injected intraperitoneally with PBS containing 5 mM EDTA, and the resident
peritoneal cells were harvested. Peritoneal cells were counted and seeded into 12-well plates at a density
of 5 105 cells/well in RPMI 1640 supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, and
100 mg/ml streptomycin. Cells were incubated at 37°C in a humidiﬁed atmosphere containing 5% CO2
overnight. The next day, nonadherent cells were removed by gently washing them with prewarmed PBS.
Peritoneal macrophages were either left untreated or activated with 100 ng/ml IFN-/LPS for 4 h prior
to coincubation with C. albicans.
Flow cytometry analysis. Macrophages were detached by incubation with ice-cold 5 mM EDTA in
PBS for 15 min. Cells were washed once with FACS buffer (1% [wt/vol] BSA–0.5 mM EDTA in PBS),
followed by an Fc receptor blockade with human Fc Block (BD Biosciences) in FACS buffer for 10 min at
room temperature. Cells were stained for surface antigens with ﬂuorochrome-conjugated (Brilliant Violet
421, FITC, phycoerythrin [PE]-Cy7, peridinin chlorophyll protein [PerCP]-Cy5.5, antigen-presenting cells
[APC]) antibodies against human CD14 (MP9), CD68 (Y1/82A), CD80 (L307.4), CD163 (GHI/61), and
CD206 (19.2) (BD Biosciences) for 30 min at room temperature in the dark. Cells were washed once with
FACS buffer before being ﬁxed with 4% formaldehyde and analyzed by ﬂow cytometry within 24 h.
Samples were acquired using a BD LSRII ﬂow cytometer equipped with BD FACS Diva software (BD
Bioscience). FlowJo (TreeStar) was used for the ﬁnal analysis.
C. albicans caspofungin and thimerosal treatment and chitin extraction. C. albicans strains used
in this study are listed in Table 1 and were maintained as glycerol stocks at80°C. When required, strains
were plated onto YPD agar (1% [wt/vol] yeast extract, 2% [wt/vol] peptone, 2% dextrose, and 2% agar)
and incubated at 30°C for 48 h. Fungal chitin from C. albicans yeast cells was extracted and puriﬁed as
described previously (12). For Candida-macrophage cocultures, yeast cells were precultured twice in
10 ml YPD broth, ﬁrst for 16 h at 25°C at 200 rpm and then for 24 h at 37°C at 200 rpm. Yeast cells were
harvested, washed three times with sterile PBS, counted, and diluted to the desired density. To obtain
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caspofungin-treated yeast cells that presented chitin on their cell surfaces, yeast cells were inoculated to
stationary phase in YPD broth at 30°C at 200 rpm and then diluted in fresh YPD broth (starting optical
density at 600 nm [OD600]  0.2) and grown to mid-exponential phase in the presence or absence of
caspofungin (3.2 g/ml). Cells were washed three times with PBS and incubated with 50 mM thimerosal
overnight in the dark before being washed repeatedly with PBS and used for stimulation assays or
staining for cell wall chitin exposure. Inactivation of C. albicans cells by thimerosal was conﬁrmed by
plating cells onto YPD agar and incubating them at 30°C for 5 days.
Phagocytosis assay. Following coincubation with C. albicans for 3 h at 37°C in a humidiﬁed
atmosphere containing 5% CO2, samples were ﬁxed with 4% (wt/vol) paraformaldehyde overnight at 4°C.
Cells were washed three times with PBS and blocked with goat serum (1/20) in PBS for 30 min at room
temperature. Nonphagocytosed Candida cells were stained with a ﬂuorochrome-conjugated rabbit
polyclonal anti-C. albicans antibody (Acris Antibodies) diluted 1/250 in 1% (wt/vol) BSA in PBS for 1 h at
room temperature, followed by three washes with 0.05% (wt/vol) BSA in PBS containing 0.05% (vol/vol)
Tween 20 (BSA/PBS-T). Macrophages were permeabilized with 0.5% (vol/vol) Triton X-100 in PBS for
10 min at room temperature, and then samples were washed three times with BSA/PBS-T and incubated
with ﬂuorochrome-conjugated phalloidin (1/1,000; Sigma-Aldrich) and 10 g/ml calcoﬂuor white (CFW)
to distinguish nonphagocytosed (FITC- and CFW-positive) from phagocytosed (CFW-positive) fungal cells.
Fluorescence was observed with a Zeiss Axio Observer Z1 microscope equipped with a Zeiss MRm digital
camera and Zeiss AxioVision software. Images were analyzed with ImageJ. Phagocytic activity was
calculated as a phagocytic index (PI) as described before (48), using the following formula: PI 
(percentage of phagocytic cells containing 1 Candida cell)  (mean number of Candida cells/
phagocytic cell containing Candida).
Candida killing assay. Activated macrophages were coincubated with C. albicans for 3 h at 37°C in
a humidiﬁed atmosphere containing 5% CO2. To determine the killing of C. albicans by macrophages, the
supernatant was removed and macrophages were lysed in 200 l 0.01% SDS in water to release fungal
cells. A serial dilution was performed and plated onto YPD agar. After an incubation period of 24 h at
30°C, numbers of CFU were counted and Candida survival/killing was determined by comparing
cocultures to C. albicans control cultures without macrophages.
Immunoblots. Protein expression was analyzed by Western blot analysis. After coincubation, mac-
rophages were washed once with ice-cold PBS before proteins were extracted by lysing cells with 2
Laemmli buffer (49). Samples were heated for 10 min at 95°C and centrifuged for 5 min at 13,000 rpm
to pellet cellular debris. Protein samples (20 l) were separated by SDS-PAGE using the XCell SureLock
minicell system (Invitrogen) with NuPAGE Novex Bis-Tris 4 to 12% precast gels (Invitrogen) in NuPAGE
MOPS (morpholinepropanesulfonic acid)-SDS running buffer (Invitrogen) as per the manufacturer’s
instructions. Proteins were then transferred to Invitrolon polyvinyl diﬂuoride (PVDF) membranes (Invit-
rogen) in NuPAGE transfer buffer using the XCell II blot module (Invitrogen). Following transfer, the
membranes were blocked in 10% (wt/vol) nonfat dry milk in TBS-T (0.1% Tween 20 in TBS) for 1 h at room
temperature. Membranes were washed with TBS-T and incubated with primary antibodies in 5% BSA in
TBS-T overnight at 4°C, followed by incubation with appropriate horseradish peroxidase (HRP)-
conjugated secondary antibodies diluted in 5% BSA–TBS-T for 1 h at room temperature. Arginase-1 was
detected using a polyclonal sheep anti-arginase 1 antibody (1/200; R&D Systems), followed by rabbit
anti-sheep IgG-HRP (1/1,000; Abcam, Inc.); iNOS was detected using a rabbit polyclonal anti-NOS
(pan)antibody (1/500; Cell Signaling) followed by goat anti-rabbit IgG-HRP (1/1,000; Cell Signaling), and
-actin was detected using an HRP-conjugated rabbit monoclonal anti--actin antibody (1/1,000; Cell
Signaling). Membranes were washed in TBS-T, and signals were detected using the LumiGLO chemilu-
minescent substrate (Cell Signaling). Signals were quantiﬁed using a Fusion FX7/SL chemiluminescence
and ﬂuorescence combination imaging system.
Arginase activity and NO production assays. Arginase activity was determined using the arginase
activity assay kit (Sigma-Aldrich) by following the manufacturer’s instructions. In short, macrophages
were washed once with ice-cold PBS before being lysed for 10 min by the addition of 100 l of 0.4%
Triton X-100 in 10 mM Tris-HCl, pH 7.4, supplemented fresh with 1 M pepstatin A and 1 M leupeptin.
Samples were centrifuged for 10 min at 4°C and 13,000 rpm to remove cellular debris. Lysates were
transferred into fresh tubes and stored at 20°C until analyzed. Nitric oxide production was determined
using the Griess reagent kit for nitrite determination (Molecular Probes).
Cell wall staining. C. albicans cells were harvested by washing macrophages with PBS to collect
nonphagocytosed fungal cells. Macrophages were then lysed with 0.01% SDS in water to release
phagocytosed fungal cells. Fungal cells were washed three times with FACS buffer (1% [wt/vol]
BSA–0.5 mM EDTA in PBS) and blocked with 5% goat serum for 30 min at room temperature before
being stained with 5 g/ml puriﬁed human Fc–dectin-1 for 1 h on ice. Samples were repeatedly washed
before being incubated with ﬂuorochrome-conjugated anti-human IgG Fc antibody (1/250; Life Tech-
nologies, Inc.) and ﬂuorochrome-conjugated wheat germ agglutinin (WGA-FITC) (100 g/ml; Sigma-
Aldrich) for 45 min on ice. Cells were washed and stained with CFW (25 g/ml; Sigma-Aldrich) for 10 min
before being intensively washed and ﬁnally ﬁxed with 4% (wt/vol) paraformaldehyde. Fluorescence was
observed with a Zeiss Imager M2 equipped with a Zeiss MRm digital camera and Zeiss AxioVision
software. Images were analyzed with ImageJ.
Statistical analyses. All experiments included two biological replicates per donor and were per-
formed at least 3 times, with the exception of the experiments whose results are shown in Fig. 5 and S1
(performed twice), and revealed comparable results. Values are presented as means  standard devia-
tions (SD) (n  the number of blood donors/mouse). Statistical signiﬁcance was determined using
GraphPad Prism 5 (as applicable) using a two-tailed paired Student t test and one-way analysis of
Wagener et al. ®
January/February 2017 Volume 8 Issue 1 e01820-16 mbio.asm.org 12
 
m
bio.asm
.org
 o
n
 January 31, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
variance (ANOVA) followed by Tukey post hoc analysis. A P value of 0.05 or less was considered
signiﬁcant.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mBio.01820-16.
FIG S1, TIF ﬁle, 0.9 MB.
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